Higend
Higend is a Singapore-based biotech company focused on developing treatments for I&I diseases. HGA001 is our lead program, first and only long-acting anti-OSMR antibody at IND-enabling stage developing for IBD/AD/IPF indications. We are actively looking for ex-China partners now.